drugset / Trial / NCT00332826
Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma
RandomizedParallel-groupOpen-labelTreatment
Summary
The clinical trial is designed to evaluate the safety of inhaled Technosphere/Insulin compared with non-inhaled anti-diabetic therapies in subjects with type 1 or type 2 diabetes mellitus and concurrent asthma.
Timeline
- Start
- 2006-06
- Primary completion
- 2007-10
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | — | Inhaled |